Trevi Therapeutics (TRVI) Profit After Tax Growth (1y) (2019 - 2026)
Trevi Therapeutics (TRVI) Profit After Tax Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
66.06% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.05% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-632.44% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Trevi Therapeutics |
2.08 Bn |
1.91 Bn |
- |
-27.58% |
| Date | Value |
|---|
| Mar 31, 2026 |
-27.58% |
| Dec 31, 2025 |
27.15% |
| Sep 30, 2025 |
10.87% |
| Jun 30, 2025 |
0.41% |
| Mar 31, 2025 |
5.16% |
| Dec 31, 2024 |
-45.95% |
| Sep 30, 2024 |
-72.02% |
| Jun 30, 2024 |
-72.88% |
| Mar 31, 2024 |
-70.32% |
| Dec 31, 2023 |
-42.07% |
| Sep 30, 2023 |
6.87% |
| Jun 30, 2023 |
11.26% |
| Mar 31, 2023 |
12.66% |
| Dec 31, 2022 |
35.08% |
| Sep 30, 2022 |
-13.94% |
| Jun 30, 2022 |
17.79% |
| Mar 31, 2022 |
12.45% |
| Dec 31, 2021 |
11.34% |
| Sep 30, 2021 |
1.67% |
| Jun 30, 2021 |
-32.64% |
